Search
bioresorbable scaffold
Contraindications:
- use as a resorbable coronary stent with PCI [1]
* no benefit, potential risk [1]
Related
coronary stent/coronary stenting
General
device (medical device)
References
- Serruys PW, Chevalier B, Sotomi Y, et al.
Comparison of an everolimus-eluting bioresorbable scaffold
with an everolimus-eluting metallic stent for the treatment of
coronary artery stenosis (ABSORB II): A 3 year, randomised,
controlled, single-blind, multicentre clinical trial.
Lancet 2016 Oct 28;
PMID: 2780689
- Byrne RA, Kastrati A.
Disappearing scaffolds, dissolving expectations.
Lancet 2016 Oct 30
PMID: 27806898